| 
            オオツボ テンペイ
            OOTSUBO Tenpei
           大坪 天平 所属 医学部 医学科(附属足立医療センター) 職種 特任教授  | 
      |
| 論文種別 | 原著 | 
| 言語種別 | 英語 | 
| 査読の有無 | 査読あり | 
| 表題 | Effect of high-dose milnacipran in patients with depression. | 
| 掲載誌名 | 正式名:Neuropsychiatric disease and treatment 略 称:Neuropsychiatr Dis Treat ISSNコード:11766328/11766328  | 
| 掲載区分 | 国外 | 
| 巻・号・頁 | 3(5),pp.699-702 | 
| 著者・共著者 | Hayashi Masatoshi, Mimura Masaru, Otsubo Tempei, Kamijima Kunitoshi | 
| 発行年月 | 2007 | 
| 概要 | To investigate the antidepressant effect of high-dose milnacipran, we retrospectively compared three groups of inpatients with major depression; those who were given milnacipran >100-150 mg/day (high-dose milnacipran group), those treated with milnacipran at maximum doses of 50-100 mg/day (standard-dose milnacipran group), and those treated with paroxetine at maximum doses of 40 mg/day (paroxetine group). The Hamilton Depression Rating Scale (HAM-D) scores of the three groups showed significant decrease at discharge compared to the scores at admission, indicating improvement of depressive symptoms for each group. However, the mean HAM-D score on admission was significantly lower for the standard-dose milnacipran group than the high-dose milnacipran and paroxetine groups. Additional intermediate assessment of the high-dose milnacipran group showed that the effect of milnacipran was dose-dependent with an additional improvement when patients were increase from 100 to 150 mg/day. These results suggest that patients suffering from moderate to severe depression with relative high HAM-D scores may benefit from treatment with high-dose milnacipran. | 
| PMID | 19300602 |